Email Alert | RSS

Journal of Peking University (Health Sciences) ›› 2020, Vol. 52 ›› Issue (3): 438-443. doi: 10.19723/j.issn.1671-167X.2020.03.007

Previous Articles     Next Articles

Effect of benzo(a)pyrene on dopaminergic neurons and α-synuclein in brain and its mechanism involved

Yu-ze QI,Hui-hui QUAN,Wei-xing XU,Qing-ru LI,Hui ZHOU()   

  1. Department of Occupational and Environmental Health, Peking University School of Public Health, Beijing 100191, China
  • Received:2020-02-18 Online:2020-06-18 Published:2020-06-30
  • Contact: Hui ZHOU E-mail:zhouhui@bjmu.edu.cn
  • Supported by:
    National Natural Science Foundation of China(21577004);Natural Science Foundation of Beijing(7162104)

RICH HTML

 11   

PDF (PC)

255

Abstract:

Objective: To analyze the effect of benzopyrene on the decrease of dopaminergic neurons, and the increase and aggregation of α-synuclein, which are the pathological features of Parkinson’s disease, and to explore its possible mechanisms.Methods: Eight-month-old transgenic mice with human SNCA gene were randomly divided into a BaP-exposed group and a control group. BaP and solvent corn oil were injected intraperitoneally to BaP-exposed group and control group respectively, once a day for 60 days. The motor dysfunction of mice was tested by rotarod test. The effects of BaP on the decrease of dopaminergic neurons and increase and aggregation of α-synuclein were observed by immunohistochemistry and Western blot experiments respectively, and the expression of related mRNA was detected by quantitative real-time PCR (qRT-PCR). Twenty genes were tested in the study, mainly related to neurotransmitter transporter (2 genes), neurotransmitter receptor function (10 genes), cellular autophagy (5 genes), and α-synuclein aggregation and degradation (3 genes).Results: After BaP exposure, the movement time of the mice in the rotarod test was significantly reduced (P<0.05). The substantia nigra dopami-nergic neurons in the mice were significantly reduced, which was 62% of the control group (P<0.05), and the expression of α-synuclein in the midbrain increased, which was 1.36 times that of the control group (P<0.05). After BaP exposure, mRNA expressions of 14 genes in the midbrain of the mice were significantly down-regulated (P<0.05). Alpha-synuclein degradation and cell autophagy (5 genes), neuron transporters (2 genes), and neurotransmitter receptor functions (5 genes) were involved. The expression of one gene, Synphilin-1, was significantly up-regulated (P<0.01), which was related to α-synuclein aggregation.Conclusion: BaP exposure not only inhibited function of neurotransmitter receptor and dopamine transporter, but also interfered cell autophagy, thereby hindering the degradation of α-synuclein, which could lead to decrease of dopaminergic neurons in substantia nigra and increase and aggregation of α-synuclein in midbrain, as the significant pathology of Parkinson’s disease. Therefore, BaP exposure may increase the risk of Parkinson’s disease.

Key words: Benzo(a)pyrene, Dopaminergic neurons, Alpha-synuclein, Parkinson’s disease

CLC Number: 

  • R12

Table 1

Primer sequences of the target gene"

Genes Forward primer Reverse primer
Alphy-syn degradation and cell autophagy
Beclin1 ATGGAGGGGTCTAAGGCGTC TGGGCTGTGGTAAGTAATGGA
LC3-Ⅱ GACCGCTGTAAGGAGGTGC CTTGACCAACTCGCTCATGTTA
Hspa1a TGGTGCAGTCCGACATGAAG GCTGAGAGTCGTTGAAGTAGGC
Hsc70 TCTCGGCACCACCTACTCC CCCGATCAGACGTTTGGCA
Hsp90 CCAGCAAACAGGACCGAAC GCAATGGTGCCAAGGTTATTGAT
Neurotransmitter transporter
DAT GATGCACATAGCAGCAACTCT GCACACCACGCTCAAAATACTC
Vmat2 ATGCTGCTCACCGTCGTAG GGCAGTCTGGATTTCCGTAGT
Alphy-syn aggregate formation
Synphilin-1 CTTCCCTCTAATGCGCTGGTT CGTTGCGTTTCTTTTGATGTCA
Septin4 ACGGAATCGCAACAAACTGAC TCTTTCTCCCGGATTAGCTTCTC
GAK GGATGGAGCAAAACTTCGGAT TGGAAGACTGTGTAACGAGTGT
Neurotransmitter receptor
Htr1a GACAGGCGGCAACGATACT CCAAGGAGCCGATGAGATAGTT
Htr1d CACCCGCACCTGGAACTTT AGTGGAGGGATGGAGATACAAA
Htr5b CTGGTGAGCGAGTTGTCCG GCGTGATAGTCCAGTAGCGA
Adora2a TTCCACTCCGGTACAATGGC CGATGGCGAATGACAGCAC
Adra1b ACATTGGGGTGCGATACTCTC TTGGGCGCAGGTTCTTTCC
Drd1 GACATACGCCATTTCATCCTCC ATGCGCCGGATTTGCTTCT
Drd2 CAAGCGCCGAGTTACTGTCAT ATGGAGGAGTAGACCACGAAG
Gabra5 TTGGACGGACTCTTGGATGG TGTTCGCACCTGCGTGATT
Hrh3 CTCCGCACCCAGAACAACTT GCACGATGTTGAAGACTGAGG
Lepr GTCTTCGGGGATGTGAATGTC ACCTAAGGGTGGATCGGGTTT

Figure 1

Change of the drop time of rotarod test * P<0.05, compared with the control group."

Figure 2

Immunohistochemistry of dopaminergic neuron in the substantia nigra TH-IR, tyrosine hydroxylase immunoreactivity; SN, substantia nigra. * P<0.05, compared with the control group."

Figure 3

Changes in the expression of α-syn in the midbrain * P<0.05, compared with the control group."

Table 2

Effect of BaP exposure on gene expression"

Genes Multiple of change P value
Alphy-syn degradation and cell autophagy
Beclin1 0.34 0.026
LC3-Ⅱ 0.43 0.023
Hsc70 0.29 0.026
Hspa1a 0.22 0.023
Hsp90 0.33 0.030
Neurotransmitter transporter
DAT 0.24 0.018
Vmat2 0.12 0.032
Alphy-syn aggregate formation
Synphilin-1 3.52 0.016
Septin4 0.18 0.006
GAK 0.50 0.140
Neurotransmitter receptor
Htr1a 0.26 0.007
Htr5b 0.20 0.005
Gabra5 0.26 0.007
Hrh3 0.26 0.008
Lepr 0.31 0.030
Htr1d 0.45 0.140
Adora2a 0.80 0.757
Adra1b 0.40 0.107
Drd1 0.78 0.582
Drd2 0.53 0.155
[1] Saunders C, Shockley D, Knuckles M. Behavioral effects induced by acute exposure to benzo(a)pyrene in F-344 rats[J]. Neurotox Res, 2001,3(6):557-579.
pmid: 15111245
[2] Qiu CY, Cheng SQ, Xia YY, et al. Effects of subchronic benzo(a)pyrene exposure on neurotransmitter receptor gene expression in the rat hippocampus related with spatial learning and memory change[J]. Toxicology, 2011,289(2-3):83-90.
doi: 10.1016/j.tox.2011.07.012 pmid: 21839799
[3] Gao DX, Wu MF, Wang CG, et al. Chronic exposure to low benzo[a]pyrene level causes neurodegenerative disease-like syndromes in zebrafish (Danio rerio)[J]. Aquat Toxicol, 2015,167(10):200-208.
[4] Burre J, Sharma M, Tsetsenis T, et al. Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro[J]. Science, 2010,329(5999):1663-1667.
doi: 10.1126/science.1195227 pmid: 20798282
[5] Naughton C, O’toole D, Kirik D, et al. Interaction between subclinical doses of the Parkinson’s disease associated gene, alpha-synuclein, and the pesticide, rotenone, precipitates motor dysfunction and nigrostriatal neurodegeneration in rats[J]. Behav Brain Res, 2017,316(1):160-168.
[6] Wilson W, Shapiro L, Bradner J, et al. Developmental exposure to the organochlorine insecticide endosulfan damages the nigrostriatal dopamine system in male offspring[J]. Neurotoxicology, 2014,44(9):279-287.
[7] Ali S, Rajini P. Elicitation of dopaminergic features of Parkinson’s disease in C. elegans by monocrotophos, an organophosphorous insecticide[J]. CNS Neurol Disord Drug Targets, 2012,11(8):993-1000.
doi: 10.2174/1871527311211080008 pmid: 23244418
[8] Palacios N, Fitzgerald K, Hart J, et al. Air pollution and risk of Parkinson's disease in a large prospective study of men[J]. Environ Health Perspect, 2017,125(8):1-7.
[9] Lee P, Liu L, Sun Y, et al. Traffic-related air pollution increased the risk of Parkinson’s disease in Taiwan: A nationwide study[J]. Environ Int, 2016,96(11):75-81.
[10] Das M, Seth P, Mukhtar H. Distribution of benzo(a)pyrene in discrete regions of rat brain[J]. Bull Environ Contam Toxicol, 1985,35(4):500-504.
pmid: 4052652
[11] Michaelson J, Trump S, Rudzok S, et al. Transcriptional signatures of regulatory and toxic responses to benzo-[a]-pyrene exposure[J]. BMC Genomics, 2011,12(10):502-515.
[12] Jayasekara S, Sharma R, Drown D. Effects of benzo[a]pyrene on steady-state levels of biogenic amines and metabolizing enzymes in mouse brain regions[J]. Ecotoxicol Environ Saf, 1992,24(1):1-12.
[13] Naoi M, Maruyama W, Nagy G. Dopamine-derived salsolinol derivatives as endogenous monoamine oxidase inhibitors: occurrence, metabolism and function in human brains[J]. Neurotoxicology, 2004,25(1-2):193-204.
[14] Stephanou P, Konstandi M, Pappas P, et al. Alterations in central monoaminergic neurotransmission induced by polycyclic aromatic hydrocarbons in rats[J]. Eur J Drug Metab Pharmacokinet, 1998,23(4):475-481.
[15] Bouayed J, Desor F, Rammal H, et al. Effects of lactational exposure to benzo[alpha]pyrene (B[alpha]P) on postnatal neurodevelopment, neuronal receptor gene expression and behaviour in mice[J]. Toxicology, 2009,259(3):97-106.
[16] Guillot T, Richardson J, Wang M, et al. PACAP38 increases vesicular monoamine transporter 2 (VMAT2) expression and attenuates methamphetamine toxicity[J]. Neuropeptides, 2008,42(4):423-434.
doi: 10.1016/j.npep.2008.04.003
[17] Giasson B, Duda J, Quinn S, et al. Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein[J]. Neuron, 2002,34(4):521-533.
[18] Webb J, Ravikumar B, Atkins J, et al. Alpha-synuclein is degraded by both autophagy and the proteasome[J]. J Biol Chem, 2003,278(27):25009-25013.
[19] Beilina A, Cookson M. Genes associated with Parkinson’s disease: Regulation of autophagy and beyond[J]. J Neurochem, 2016,139(10):91-107.
[20] Crews L, Spencer B, Desplats P, et al. Selective molecular alterations in the autophagy pathway in patients with Lewy body disease and in models of alpha-synucleinopathy[J]. PLoS One, 2010,5(2):e9313.
[1] ZHANG Hui-feng, HUANG Huan-huan, ZHAO Yu-jia, LI Qing-ru, QI Yu-ze, ZHOU Hui. Effects of benzo(a)pyrene on expressions of insulin-degrading enzyme and neprilysin in neuroglia cells [J]. Journal of Peking University(Health Sciences), 2018, 50(3): 401-407.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
[1] Author. English Title Test[J]. Journal of Peking University(Health Sciences), 2010, 42(1): 1 -10 .
[2] . [J]. Journal of Peking University(Health Sciences), 2009, 41(2): 188 -191 .
[3] . [J]. Journal of Peking University(Health Sciences), 2009, 41(3): 376 -379 .
[4] . [J]. Journal of Peking University(Health Sciences), 2009, 41(4): 459 -462 .
[5] . [J]. Journal of Peking University(Health Sciences), 2010, 42(1): 82 -84 .
[6] . [J]. Journal of Peking University(Health Sciences), 2007, 39(3): 319 -322 .
[7] . [J]. Journal of Peking University(Health Sciences), 2007, 39(3): 333 -336 .
[8] . [J]. Journal of Peking University(Health Sciences), 2007, 39(3): 337 -340 .
[9] . [J]. Journal of Peking University(Health Sciences), 2007, 39(3): 225 -328 .
[10] . [J]. Journal of Peking University(Health Sciences), 2007, 39(4): 346 -350 .
Copyright © Journal of Peking University (Health Sciences), All Rights Reserved.
Powered by Beijing Magtech Co. Ltd